文献速递肺外科

年轻早期非小细胞肺癌患者肺段切除与肺叶切除比较

Segmentectomy versus lobectomy in younger patients with early-stage non-small cell lung cancer.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

本研究纳入388例<70岁、影像实性为主、临床IA期≤2cm的非小细胞肺癌患者,比较肺段切除(n=114)与肺叶切除(n=274)的预后。倾向性评分匹配后两组总生存与无复发生存均无显著差异,5年和8年限制性平均生存时间差异亦无统计学意义,提示肺段切除对年轻患者是可行选择,适应证不必因年龄而异。

要点

  • 年轻早期NSCLC患者肺段切除与肺叶切除的OS和RFS无显著差异。
  • 倾向性评分匹配后两组生存结果仍相当。
  • 5年和8年RMST差异均无统计学意义,支持肺段切除用于年轻患者。

核心结论

  • 肺段切除是年轻早期NSCLC患者的可行选择,肺段切除适应证不必因年龄而异。

研究设计与样本

  • 多中心回顾性队列研究,纳入2010至2017年三家机构<70岁、影像实性为主、临床IA期≤2cm的NSCLC患者388例。
  • 采用倾向性评分调整年龄、性别、吸烟史、肿瘤位置、大小、磨玻璃影、最大标准化摄取值和组织学类型等混杂因素。
  • 计算0至5年和8年限制性平均生存时间(RMST)以评估术后远期预后影响。

主要发现

  • 肺段切除组114例与肺叶切除组274例的总生存(HR 0.447;95%CI 0.152-1.316)和无复发生存(HR 0.638;95%CI 0.335-1.216)无显著差异。
  • 倾向性评分匹配100对后,肺段切除与肺叶切除的总生存(HR 0.577;95%CI 0.162-2.056)和无复发生存(HR 0.945;95%CI 0.408-2.191)相当。
  • 肺段切除与肺叶切除的5年RMST分别为4.95年与4.92年(差异0.02年;95%CI -0.09-0.13;P=0.699)。
  • 肺段切除与肺叶切除的8年RMST分别为7.82年与7.69年(差异0.12年;95%CI -0.17-0.42;P=0.420)。

临床怎么用

  • 对于<70岁、影像实性为主、临床IA期≤2cm的NSCLC患者,肺段切除可作为肺叶切除的替代术式。
  • 肺段切除的适应证选择无需仅因患者年龄较轻而排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Despite clinical trials supporting the efficacy of segmentectomy for early-stage non-small cell lung cancer (NSCLC), a previous report indicated its limited efficacy in younger patients, raising concerns about its indication. METHODS: Patients aged <70 years with radiologically solid-dominant clinical stage IA NSCLC ≤2 cm who underwent lobectomy or segmentectomy at three institutions between 2010 and 2017 were enrolled. Propensity scores were estimated to adjust for confounding variables (age, sex, smoking history, tumour location, size, ground-glass opacity, maximum standardized uptake value and histological type). To elucidate the prognostic impact of surgical indications in the late postoperative phase, restricted mean survival time (RMST) from 0 to 5 and 8 years was also determined. RESULTS: Overall, 388 patients with a median age of 63 years were enrolled. Overall survival (OS) (hazard ratio [HR], 0.447; 95% confidence interval [CI], 0.152-1.316) and recurrence-free survival (RFS) (HR, 0.638; 95% CI, 0.335-1.216) did not differ significantly between the segmentectomy (n = 114) and lobectomy groups (n = 274). In the propensity score matching of 100 pairs, OS (HR, 0.577; 95% CI, 0.162-2.056) and RFS (HR, 0.945; 95% CI, 0.408-2.191) were comparable between the segmentectomy and lobectomy groups. Regarding OS in the segmentectomy and lobectomy groups, the 5- and 8-year RMST were 4.95 years versus 4.92 years (difference: 0.02 years; 95% CI, -0.09-0.13; P = 0.699) and 7.82 years versus 7.69 years (difference: 0.12 years; 95% CI, -0.17-0.42; P = 0.420), respectively. CONCLUSIONS: Segmentectomy is a viable option for younger patients with early-stage NSCLC, suggesting that indications for segmentectomy need not vary by age.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kamigaichi A, Mimae T, Tsubokawa N, et al. Segmentectomy versus lobectomy in younger patients with early-stage non-small cell lung cancer. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 39928361. doi:10.1093/icvts/ivaf024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。